EFFECTIVENESS AND TOXICITY OF PEGYLATED LIPOSOMAL DOXORUBICIN FOR ADVANCED OVARIAN CANCER

被引：0
|
作者：
Sequeira, I. [1 ]
Simas, A. [1 ]
Brandao, M. [1 ]
Savva-Bordalo, J. [1 ]
Pereira, D. [1 ]
机构：
[1] Inst Portugues Oncol Porto Francisco Gentil, Med Oncol, Oporto, Portugal
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2015年 / 25卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO-0929
引用
收藏
页码：1491 / 1491
页数：1
相关论文
共 50 条
  • [1] Efficacy and toxicity profile of pegylated liposomal doxorubicin in patients with advanced ovarian cancer
    Mayer, Christine
    Brucker, Janina
    Schuetz, Florian
    Domschke, Christoph
    Bechstein, Sarah
    Heil, Joerg
    Golatta, Michael
    Wallwiener, Markus
    Sohn, Christof
    Schneeweiss, Andreas
    Rom, Joachim
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2016, 294 (01) : 123 - 129
  • [2] Efficacy and toxicity profile of pegylated liposomal doxorubicin in patients with advanced ovarian cancer
    Christine Mayer
    Janina Brucker
    Florian Schuetz
    Christoph Domschke
    Sarah Bechstein
    Jörg Heil
    Michael Golatta
    Markus Wallwiener
    Christof Sohn
    Andreas Schneeweiss
    Joachim Rom
    [J]. Archives of Gynecology and Obstetrics, 2016, 294 : 123 - 129
  • [3] Pegylated liposomal doxorubicin in ovarian cancer
    Green, Andrew E.
    Rose, Peter G.
    [J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2006, 1 (03): : 229 - 239
  • [4] Pegylated liposomal doxorubicin in ovarian cancer treatment
    Nowak-Markwitz, Ewa
    [J]. GINEKOLOGIA POLSKA, 2009, 80 (08) : 615 - 619
  • [5] Pegylated liposomal Doxorubicin in Recurrent Ovarian Cancer
    Lorenz, Judith
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (11)
  • [6] Pegylated Liposomal Doxorubicin in the Management of Ovarian Cancer
    Ferrandina, Gabriella
    Petrillo, Marco
    Licameli, Angelo
    Fuoco, Gilda
    Scambia, Giovanni
    Corrado, Giacomo
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 261 - 270
  • [7] Pegylated liposomal doxorubicin in the management of ovarian cancer
    Ferrandina, Gabriella
    Corrado, Giacomo
    Licameli, Angelo
    Lorusso, Domenica
    Fuoco, Gilda
    Pisconti, Salvatore
    Scambia, Giovanni
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 : 463 - 483
  • [8] Role of pegylated liposomal doxorubicin in ovarian cancer
    Thigpen, JT
    Aghajanian, CA
    Alberts, DS
    Campos, SM
    Gordon, AN
    Markman, M
    McMeekin, DS
    Monk, BJ
    Rose, PG
    [J]. GYNECOLOGIC ONCOLOGY, 2005, 96 (01) : 10 - 18
  • [9] Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
    Zhen Yuan
    Ying Zhang
    Dongyan Cao
    Keng Shen
    Qingshui Li
    Guonan Zhang
    Xiaohua Wu
    Manhua Cui
    Ying Yue
    Wenjun Cheng
    Li Wang
    Pengpeng Qu
    Guangshi Tao
    Jianqing Hou
    Lixin Sun
    Yuanguang Meng
    Guiling Li
    Changzhong Li
    Huirong Shi
    Yaqing Chen
    [J]. Journal of Ovarian Research, 14
  • [10] Carboplatin, pegylated liposomal Doxorubicin, and Bevacizumab in Ovarian Cancer
    Gappa, Birgit
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (08)
12345